SCHEMBL942730

SCHEMBL942730

O=C(Oc1coc(CO)cc1=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.57
KMT2A Q03164 6/20 0.56
MAPT P10636 6/20 0.56
DAO P14920 2/20 0.56
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
APLNR P35414 7/20 0.52
NPC1 O15118 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
RECQL P46063 1/20 0.51
RAB9A P51151 1/20 0.51
POLB P06746 2/20 0.50
MEN1 O00255 2/20 0.48
KDM4E B2RXH2 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3030873 0.79 KMT2A (0.54) ELANEKMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL4237894 0.79 KMT2A (0.69) ELANEKMT2AMAPTDAOALDH1A1
SCHEMBL124774 0.77 RAB9A (0.54) ELANEKMT2ADAONPC1CYP1A2
SCHEMBL2116925 0.75 RAB9A (0.75) KMT2ADAONPC1CYP1A2CYP2C19
Benzil SCHEMBL10422064 0.75 DAO (0.69) DAOKDM4E
Kojic Acid SCHEMBL942734 0.75 DAO (0.69) DAOKDM4E
SCHEMBL1686913 0.74 KMT2A (0.48) ELANEKMT2ADAONPC1CYP1A2
SCHEMBL10422065 0.74 KMT2A (0.41) ELANEKMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL3569466 0.73 DAO (0.56) KMT2AMAPTDAOALDH1A1SMN1; SMN2
SCHEMBL5070268 0.73 RAB9A (0.56) ELANEKMT2AMAPTDAONPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200289392-A1 A MELANOGENESIS INHIBITOR COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2020-09-17 US claimed
EP-3644947-A1 A MELANOGENESIS INHIBITOR COMPOSITION Dow Global Technologies LLC (US) 2020-05-06 EP claimed
CN-110769808-A Melanin production inhibitor composition 陶氏环球技术有限责任公司 2020-02-07 CN claimed
WO-2019005437-A1 A MELANOGENESIS INHIBITOR COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2019-01-03 WO claimed
EP-0308543-B1 COMPOSITIONS FOR EXTERNAL APPLICATION Sansho Seiyaku Co., Ltd. (JP) 1993-09-22 EP claimed
US-4990330-A Skin whitening and sunscreen; Kojic acid of esters, glucosamine and derivatives, cystein SANSHO SEIYAKU CO., LTD. (JP) 1991-02-05 US claimed
EP-0208799-B1 WHITENING COSMETIC COMPOSITION Sansho Seiyaku Co., Ltd. (JP) 1990-09-26 EP claimed
US-4948577-A KOJIC ACID AND 4-/1,1-DIMETHYLETHYL/-4'-METHOXY DIBENZOYLMETHANE; PREVENT COLORING OF SKIN WHEN EXPOSED TO ULTRAVIOLET LIGHT SANSHO SEIYAKU CO., LTD. (JP) 1990-08-14 US claimed
EP-0381057-A2 Chemical composition for external application Sansho Seiyaku Co., Ltd. (JP) 1990-08-08 EP claimed
US-4919921-A KOJIC ACID OR AN ESTER OF KOJIC ACID AND VITAMIN C OR A DERIVATIVE OF VITAMIN C SANSHO SEIYAKU CO., LTD. (JP) 1990-04-24 US claimed
EP-0308543-A1 Compositions for external application Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP claimed
EP-0308919-A1 Compositions for topical use having melanin synthesis-inhibiting activity Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP claimed
EP-0308918-A1 Compositions for topical use having melanin synthesis-inhibiting activity Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP claimed
WO-2024132395-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE UNILEVER IP HOLDINGS B.V. (NL) 2024-06-27 WO disclosed
EP-4308071-A1 USE OF HORDENINE FOR TREATING CELLULAR SENESCENCE Unilever IP Holdings B.V. (NL) 2024-01-24 EP disclosed
EP-4301328-A1 USE OF FRUCTANS FOR PROVIDING SKIN CARE BENEFITS Unilever IP Holdings B.V. (NL) 2024-01-10 EP disclosed
EP-0308543-A1 Compositions for external application Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP disclosed
EP-0308919-A1 Compositions for topical use having melanin synthesis-inhibiting activity Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP disclosed
US-4696813-A PLACENTA EXTRACT AND KOJIC ACID SANSHO SEIYAKU CO., LTD. (JP) 1987-09-29 US disclosed
EP-0208799-A1 Whitening cosmetic composition Sansho Seiyaku Co., Ltd. (JP) 1987-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200289392-A1 A MELANOGENESIS INHIBITOR COMPOSITION TYR, MC1R, MITF ELANE 3929/4885KMT2A 413/4885MAPT 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.